TREK™ 1012275-12Recalls & reported problems
Abbott Vascular Inc. · TREK™ Coronary Dilatation Catheter 3.25 mm x 12 mm / Rapid-Exchange · Class 2
All models of TREK (50)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 08717648138492), received between Mar 20, 2019 and Jul 19, 2023 — classified as 3 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Difficult to Remove” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Difficult to Remove4
- Material Rupture3
- Improper or Incorrect Procedure or Method2
- Material Separation2
- Difficult to Advance1
- Entrapment of Device1
- Failure to Advance1
- Fracture1
Patient problems
- Vessel Or Plaque, Device Embedded In2
- Embolism1
- Myocardial Infarction1
- No Clinical Signs, Symptoms or Conditions1
- No Consequences Or Impact To Patient1
- Occlusion1
- Pulmonary Edema1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 19, 2023Difficult to Remove; Failure to Advance; Difficult to Remove; Failure to Advance
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION IN THE RIGHT CORONARY ARTERY (RCA) WITH MODERATE CALCIFICATION AND MODERATE TORTUOSITY. THE 3.25X12MM TREK RX BALLOON DILATATION CATHETER (BDC) WAS ADVANCED TO THE TARGET LESION; HOWEVER, THE BDC FAILED TO CROSS IT. THEREFORE, THE BDC WAS REMOVED AND RESISTANCE WAS ALSO NOTED WITH THE LESION. A NON-ABBOTT BALLOON WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY REPORTED IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17351717 ↗InjuryDec 2, 2020Difficult to Remove; Material Rupture; Material Separation; Difficult to Advance; Difficult to Remove; Material Rupture; Material Separation; Difficult to Advance
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT AN OCCLUDED LESION LOCATED IN THE PROXIMAL LEFT ANTERIOR DESCENDING (PLAD), LEFT MAIN (LM) AND LEFT CIRCUMFLEX CORONARY (LCX) ARTERIES. A 3.0X33MM XIENCE SIERRA STENT WAS IMPLANTED IN THE LCX. KISSING BALLOON WAS THEN TO BE PERFORMED. A 3.25X12MM TREK BALLOON WAS ADVANCED WITH SLIGHT RESISTANCE INTO THE LCX. WHEN THE 3.5X12MM TREK BALLOON WAS PLACED IN THE LM/PLAD, THERE WAS SLIGHT MOVEMENT OF THE BALLOON IN THE LCX. AN ATTEMPT WAS MADE TO REMOVE THE BALLOON FROM THE LCX, BUT IT WAS STUCK. TROUBLE SHOOTING WAS PERFORMED AND THE BALLOON WAS REMOVED WITH RESISTANCE, AND ONCE REMOVED, IT WAS NOTED THAT THE BALLOON WAS TORN AND THE LCX WAS OCCLUDED. OPTICAL COHERENCE TOMOGRAPHY (OCT) WAS PERFORMED AND A PIECE OF BALLOON WAS NOTED ATTACHED TO THE 3.0X33MM XIENCE SIERRA STENT IN THE LCX. THE PIECE OF THE BALLOON WAS NOT ABLE TO BE REMOVED AND REMAINS IN THE PATIENT. THE PATIENT EXPERIENCED AN ACUTE MYOCARDIAL INFARCTION AND ACUTE LUNG EDEMA AND WAS TRANSFERRED TO THE INTENSIVE CARE UNIT AND PLACED EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO). NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Embolism; Myocardial Infarction; Pulmonary Edema
MAUDE report 10932260 ↗InjuryDec 11, 2019Fracture; Difficult to Remove
DURING PTCA PROCEDURE OF MID LEFT CIRCUMFLEX ARTERY THE BALLOON FRACTURED AND BECAME ENTRAPPED WITHIN CALCIFIED VESSEL. BALLOON WAS UNABLE TO BE RETRIEVED SO DECISION WAS MADE TO ABORT AND MONITOR PT CLOSELY IN CCU. PT EXPERIENCE NO UNTOWARD SYMPTOMS DURING STAY OR UP TO THIS WRITING. FDA SAFETY REPORT ID# (B)(4).
Patient problems: Vessel Or Plaque, Device Embedded In
MAUDE report 9458553 ↗InjuryDec 6, 2019Entrapment of Device; Material Rupture; Material Separation; Improper or Incorrect Procedure or Method; Entrapment of Device; Material Rupture; Material Separation; Improper or Incorrect Procedure or Method
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A HEAVILY CALCIFIED CIRCUMFLEX LESION. A 3.25X12MM RX TREK BALLOON RUPTURED AT 18 ATMOSPHERES ON THE SECOND INFLATION. THE BALLOON DILATATION CATHETER (BDC) MET RESISTANCE WITH THE ANATOMY DURING RETRIEVAL AND THE BALLOON SEPARATED IN THE ANATOMY. AN ATTEMPT WAS MADE TO RETRIEVE THE SEPARATED BALLOON USING AN UNSPECIFIED GUIDE LINER BUT WAS UNSUCCESSFUL AND THE BALLOON WAS LEFT IN THE VESSEL. ALTHOUGH THE VESSEL WAS TOTALLY OCCLUDED, TREATMENT WAS NOT DONE AS THE VESSEL HAD COLLATERALS TO THE AREA FROM OTHER VESSELS. ONCE THE RX TREK BECAME STUCK IN THE VESSEL, IT CONTRIBUTED TO THE BALANCE MIDDLEWEIGHT (BMW) UNIVERSAL II GUIDEWIRE AND A NON-ABBOTT GUIDEWIRE TO LOSE DISTAL ACCESS. THE GUIDE WIRE WAS REPLACED WITH A WIGGLE WIRE GUIDEWIRE. PER THE ACCOUNT, THERE WAS NO ISSUE WITH THE BMW. THERE WAS NO ADVERSE PATIENT SEQUELA REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Occlusion; Vessel Or Plaque, Device Embedded In
MAUDE report 9432803 ↗MalfunctionMar 20, 2019Difficult to Remove; Material Rupture; Improper or Incorrect Procedure or Method; Difficult to Remove; Material Rupture; Improper or Incorrect Procedure or Method
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT AN ECCENTRIC LESION IN THE MILDLY TORTUOUS, MILDLY CALCIFIED, 99% STENOSED DISTAL RIGHT CORONARY ARTERY. A 3.25X12M TREK RX BALLOON DILATATION CATHETER (BDC) WAS SOAKED IN SALINE PRIOR TO USE, BUT PREPPED (AIR ASPIRATION) INSIDE THE ANATOMY. RESISTANCE WAS FELT WHEN REMOVING THE PROTECTIVE SHEATH. THE BDC WAS ADVANCED TO THE LESION WITHOUT RESISTANCE, AND THE BALLOON RUPTURED DURING THE FIRST INFLATION AT 5 ATMOSPHERES FOR 5 SECONDS. THE BDC WAS REMOVED WITHOUT RESISTANCE AND REPLACED WITH A SAME SIZE TREK RX TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8436633 ↗
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page